We demonstrated the significant eosinophilic growth of leukemic cells in the presence of interleukin-5 (IL-5) in 2 of 15 cases of acute myeloid leukemia. These two cases were M2 (FAB classification) with the translocation (8;21 )(q22: q22). Bone marrow examination revealed the rather high percentages (6% and 9%) of atypical eosinophils in the total nucleated bone marrow cells in these two cases. In the remaining 13 cases, eosinophils were less than 2% irr the nucleated bone marrow cells. In the methylcellulose culture system, 142 f 18 or 54 f 2 colonies were formed by 5 x IO4 mononuclear cells in the presence of IL-5 in these two cases. These colonies mainly comprised mature eosinophils. Eosinophils were confirmed by Biebrich scarlet staining and electron microscopic examination using a specific lectin binding assay. The eosinophilic differentiation and proliferation of leukemic cells were also observed in the ONE MARROW eosinophilia, arbitrarily defined as 5% B or more eosinophils in the nucleated marrow bone marrow cells, has been observed in some cases of acute myeloid leukemia (AML)' that were classified as M2 and M4 according to the French-American-British (FAB) criteria.* A marked eosinophilia in the bone marrow was present in 12 of 33 cases of AML with the translocation (8;21) closely related to M2.3 M4 with eosinophilia associates the structural abnormalities of chromosome 16.4 The morphological abnormalities in eosinophils observed in AML suggested that eosinophils may be a part of leukemic process5; however, there is no evidence to prove that suggestion.
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The methylcellulose culture and suspension culture have been widely accepted as the techniques by which to study biological characteristics of AML cells? Eosinophil colony formation has been reported in cases of AML' and acute eosinophilic leukemia' using the semisolid culture system.
On the other hand, in vitro effects of various kinds of hematopoietic factors on leukemic cells have been extensively ~tudied.~.'~ However, effects of interleukin-5 (IL-5) on leukemic cells have not been clarified. and human IL-5 were IL-5 is a lineagespecific factor for the differentiation of eosinophilic precur~ors.''*'~ In this report, we studied the in vitro effects of IL-5 on leukemic cells compared with those of other hematopoietic factors by the culture of AML cells. Leukemic cells were able to proliferate and differentiate to eosinophils in the presence of IL-5 in 2 of 15 cases of AML. We found that eosinophils were derived from leukemic cells possessed of t(8;21) using the clonogenic leukemic cell assay in two cases of AML-M2.
MATERIALS AND METHODS
We studied 15 patients with AML diagnosed according to the FAB cooperative group criteria. Monoclonal antibodies (MoAbs) and cytogenetic studies were also used for the characterization of leukemic cells. All cases of AML were classified as M1 (five cases), M2 (seven cases), or M3 (three Cases). After informed consent, samples were obtained before any cytotoxic chemotherapy in all cases.
Bone marrow cells or peripheral blood cells layered over Ficoll-Metrizoate (Lymphoprep, Nygaad, Oslo) were centrifuged for 30 minutes at 400g. Interface cells were harvested and washed twice in Iscove's modified Dulbecco's medium (IMDM; GIBCO, Grand Island, NY).
Hematopoietic factors. We used purified recombinant factors as follows: recombinant human interleukin-3 (rhIL-3; specific activity, 21,900 U/mL; provided by Genetics Institute, Cambridge, MA),*" recombinant human interleukin-5 (rhIL-5; purity of 80%; provided by Suntory Central Research Institute, Osaka, Japan)," recombinant human interleukin-6 (rhIL-6; specific activity, 3.9 x IO9 U/mg protein; provided by Ajinomoto Pharmaceutical Co, Kawasaki, Japan),"' recombinant human granulocyte-macrophage colonystimulating factor (rhGM-CSF; specific activity, 1.0 x lo9 U/mg protein; provided by Sumitomo Pharmaceutical Co, Osaka, Japan),"' and recombinant human granulocyte colony-stimulating factor (rhG-CSF; specific activity 2.5 x lo7 U/mg protein; provided by Chugai Pharmaceutical Co, Tokyo, Japan)."' The optimal concentration of each hematopoietic factor was determined by titration using human normal bone marrow cells and leukemic cells as target cells.
Patients.

Leukemic cells.
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Clonal cell culture. Methylcellulose culture was performed in 35 mm non-tissue culture dishes (Falcon, Oxnard, CA) as previously de~cribed.'~ One milliliter of 5 x lo4 mononuclear cells (MNCs), 30% fetal calf serum (FCS; Flow Laboratories, North Ryde, NSW, Australia), 1% deionized bovine serum albumin (BSA, Sigma Chemical Co, St Louis, MO), 5 x lo-' mol/L 2-mercaptoethanol (2-ME Sigma) and 1.2% methylcellulose (Aldrich Chemical Co, Milwaukee, WI) in IMDM was prepared. One of the hematopoietic factors was added to that mixture as follows: 100 U/mL rhIL-3, 1 ng/mL rhIL-5, 20 ng/mL rhIL-6, 200 U/mL rhGM-CSF, or 20 ng/mL rhG-CSF. The culture was incubated at 37OC in a humidified atmosphere of 5% C 0 2 and 5% 0,. The numbers of colonies or clusters were scored on day 14 of culture using an inverted microscope. Colonies were defined as aggregations containing 40 or more cells. Clusters were defined as those containing from 8 to 39 cells. In order to analyze the morphology of cells composing colonies or clusters, individual colonies or clusters were lifted with Eppendorf micropipet and pooled in IMDM with FCS. Samples were centrifuged with Cytospin (Shandon Southern Products, Sewickley, PA) for a microscopic examination. Using the same samples, cytochemical and electron microscopic studies were also performed in some cases.
Liquid culture. IMDM with 30% FCS-suspended 1 x lo5
MNCs/mL were cultured in 25 cmz tissue culture flasks (Corning Glass, Corning, NY). One or none of the hematopoietic factors was added to the liquid culture. The concentration of each factor was the same as in the semi-solid culture. Cultures were incubated at 37OC in a humidified atmosphere of 5% CO, and 5% 0,. Half volume of the medium was replaced once a week with freshly prepared medium containing the same hematopoietic factor as the initial medium. Viable cell counts and morphological analyses of proliferated and/or differentiated cells in the liquid culture were performed weekly until the number of suspended cells became less than one tenth of the starting number.
Morphological analysis of cultured cells. May-Griinwald-
Giemsa staining was performed in each case. Differential counts of cells composing colonies in the presence of each hematopoietic factor were performed on day 14 of culture. Differential counts of suspended cells were also performed weekly. We stained cultured cells in the presence of IL-5 with Biebrich scarletz5 to distinguish eosinophils from neutrophils or with toluidine blue to distinguish basophils from eosinophils.
Samples of cells were fixed with glutaraldehyde, post-fixed with osmium tetroxide, and processed for an electron microscopic examination. For the detection of eosinophilic granules, glutaraldehyde-fixed cells were embedded in epoxyresin, cut to thin sections, and treated with colloid gold labeled soybean agglutinin.26
Freshly prepared peripheral blood cells or bone marrow cells were cultured at 37OC in a humidified atmosphere of 5% CO, in air for 24 hours. Air-dried metaphases on slide glasses were prepared for the karyotype analysis using Q-banding. The chromosome analysis of colony cells and suspended cells was also performed in cases with abnormal karyotypes as previously reported." Proliferating cells in the liquid culture on day 7 or cells lifted from colonies on day 14 were incubated with 1 ng/mL colchicine (Demecolocine; Sigma) overnight. Air-dried metaphases were analyzed as mentioned above.
Identijcation of eosinophils &y electron microscopy.
Chromosome analysis.
RESULTS
Characteristics of patients with AML. Percentages of blast cells in the peripheral blood or bone marrow varied among patients: 11 .O% to 97.8% in the peripheral blood, 40.0% to 99.5% in the bone marrow. Eosinophils accounted for 0 to 1 .O% of peripheral nucleated cells in all cases and 0 to 1.8% of bone marrow nucleated cells in all cases except two cases of M2 (6% in case 1 and 9% in case 2). Chromosome analyses of freshly prepared peripheral blood and/or bone marrow cells revealed abnormal karyotypes in 8 of 15 cases. All cases of M3 showed the translocation (15;17)(q22;qlI). The translocation (8;21)(q22;q22) was detected in two of seven cases of M2. These two cases were cases 1 and 2 with increased eosinophils in the bone marrow, which were morphologically atypical as shown by Swirsky et al.3
Response of A M L cells to various kinds of hematopoietic factors. Spontaneous colonies were observed in only one case of M1 without addition of hematopoietic factors. IL-3, G-CSF or GM-CSF supported colony and/or cluster formation by leukemic cells in 9 (3 of M1,5 of M2, and l of M3), 8 (1 of M1,4 of M2, and 3 of M3), or 3 (1 of M1, 1 of M2, and 1 of M3) of 15 cases, respectively. IL-6 had no effect on the colony formation in all cases examined. Though leukemic cells responded to more than one factor in 12 of 15 cases, the differentiation of leukemic cells occurred in only two cases (cases 1 and 2). In these two cases, IL-5 also supported the proliferation and differentiation of leukemic cells, though it had no effect in the remaining cases. We show the detailed data of these cases below.
Colony and cluster formation in two cases of A M L (M2) with t(8;21).
No colony or cluster formation was observed in the absence of hematopoietic factors in both cases. Colonies and clusters were formed in the presence of IL-5, IL-3 or G-CSF, but not in the presence of IL-6 or GM-CSF (Table 1) . Most colonies in the presence of IL-5 were large (containing more than 500 cells), concentrical, and of a dark hue in a semi-solid medium.
Differential counts of cells composing colonies were performed using May-Grunwald-Giemsa staining. Most cells in colonies formed by the stimulation of IL-5 were eosinophils in both cases. Cytoplasmic granules of these cells were 
Liquid culture of AML (M2) cells with t(8;21).
culture in the presence of IL-5, IL-3, or G-CSF. Morphological analyses of suspended cells were performed weekly. Table 2 shows the process of differentiation to mature cells. Almost all suspended cells in case 2 differentiated to mature eosinophils on day 14 of culture in the presence of IL-5. In case 1, immature eosinophils predominated in suspended cells on day 14 of culture, and subsequently, the terminal differentiation of eosinophils was achieved on day 21 of culture. Figure 2 demonstrates the morphological change of cultured cells in the presence of IL-5. Differentiated cells on day 21 were also stained with Biebrich scarlet. Eosinophilic granules in the cytoplasm were stained orange. Mature neutrophils accounted for almost all suspended cells in the presence of G-CSF until day 14 of culture in both cases. I n the presence of IL-3, increased cells were still immature cells without morphological change on day 7. as indicated in case 1. However, these cells proliferated and differentiated to neutrophils and eosinophils on day 14. Neutrophils accounted for about 30% of the total cells in the presence of IL-5 on day 21. It was difficult to discriminate mature eosinophils from mature neutrophils beyond day 21, because eosinophilic granules became denaturated. Neutrophils were also observed in suspended cells without added hematopoietic factors or with IL-6 or GM-CSF. However, the total number of cultured cells decreased less than one tenth of the starting number, and eosinophils did not appear in these conditions.
Electron microscopic examination of cultured cells grown in the presence of IL-5 showed many large granules in the cytoplasm. The granules reacted with soybean lectins that were specifically bound to eosinophilic granules (Fig 3) . We confirmed that proliferated and differentiated cells by the stimulation of IL-5 were eosinophils.
Idenrifcarion of eosinophils.
Proof of the origin of eosinophils. We examined the clonality of eosinophils using the cytogenetic marker. We obtained metaphases from a part of the total cells in the liquid culture on day 7 and colonies on day 14 of culture. All analyzable metaphases obtained from cultured cells in the presence of IL-5. IL-3. or G-CSF showed the translocation (8;21)(q22;q22) in both cases (Table 3) . Normal karyotype was not seen. The numbers of metaphases were proportional to those of proliferating cells in the presence of IL-5, IL-3, or
In addition to these findings, seven metaphases were obtained from the pool of eosinophilic colony cells that proliferated in the presence of IL-5 in case 2. These metaphases also showed the abnormal karyotype of 45. X-Y, t(8;21)(q22;q22). In case 1, the chromosome analysis of colony cells was not successful.
G-CSF.
DISCUSSION
The major finding of this report is that IL-5 is able to support the proliferation and differentiation of leukemic cells into eosinophils in methylcellulose and liquid cultures.
We examined the in vitro effects of hematopoietic factors on the proliferation and differentiation of leukemic cells in 15 cases of AML. Responses of A M L cells to IL-3. G-CSF, or GM-CSF varied from patient to patient. These data are consistent with previous reports.2R.29 Among these cases, we found two cases of M2 wherein leukemic cells proliferated and differentiated to eosinophils in the presence of IL-5. These cases were characterized by two findings: the chromosome analysis of freshly prepared leukemic cells showed the translocation (8;21)(q22;q22). and bone marrow eosinophilia (more than 5'70) was recognized in both cases.
Leukemic cells in these cases proliferated and differentiated by the stimulation of IL-5, IL-3, or G-CSF. We demonstrated that these proliferating cells in the methylcellulose and liquid culture systems with IL-5, IL-3, or G-CSF originated from leukemic cells using the cytogenetic marker of t(8;21). Furthermore, only normal karyotypes were detected by the chromosome analysis of both freshly prepared bone marrow cells and colony cells after complete remission was achieved in case 2 (data not shown).
Eosinophils derived from leukemic cells were identified by cytochemical and ultrastructual studies. However, a crystallike structure, which is one of the characteristics of eosinophil granules, was not demonstrated clearly. ever, leukemic cells did not survive over 2 months, even if supported by IL-5, IL-3 or G-CSF. It was assumed that these factors stimulated the differentiation rather than the selfrenewal in some populations of leukemic cells. From these findings, leukemic cells with t(8;21) might be correlated with the expression of IL-5 receptors. Two hypotheses are tenable: (1) The expression of IL-5 receptors was associated with the transformation of the cells, and the receptors were abnormally expressed on primitive leukemic cells. In normal hematopoiesis, IL-5 supports the terminal differentiation of eosinophil committed precursors and acts on mature eosinophils and modulates their f~nction.~" (2) Leukemic cells matured to some extent, and then expressed the receptors for
IL-
We emphasize again that the in vitro proliferation and IL-5. eosinophilic differentiation of leukemic cells by the stimulation of IL-5 correlates well to the increase of atypical eosinophils in the bone marrow of AML patients. From the difference in response of leukemic cells to each hematopoietic factor, subclassification of leukemic cell types may be possible, because the differentiation capacity of leukemic cells could be evaluated by in vitro culture.
Due to the limited number of cases studied, it is not known whether these findings are specific to M2 with t(8;21). However, we showed eosinophils derived from the leukemic clone in vitro in two cases of M2 with t(8;21).
